264 related articles for article (PubMed ID: 12189228)
1. Effects of St. John's wort on irinotecan metabolism.
Mathijssen RH; Verweij J; de Bruijn P; Loos WJ; Sparreboom A
J Natl Cancer Inst; 2002 Aug; 94(16):1247-9. PubMed ID: 12189228
[TBL] [Abstract][Full Text] [Related]
2. St. John's Wort: more implications for cancer patients.
Mansky PJ; Straus SE
J Natl Cancer Inst; 2002 Aug; 94(16):1187-8. PubMed ID: 12189216
[No Abstract] [Full Text] [Related]
3. Prediction of irinotecan pharmacokinetics by use of cytochrome P450 3A4 phenotyping probes.
Mathijssen RH; de Jong FA; van Schaik RH; Lepper ER; Friberg LE; Rietveld T; de Bruijn P; Graveland WJ; Figg WD; Verweij J; Sparreboom A
J Natl Cancer Inst; 2004 Nov; 96(21):1585-92. PubMed ID: 15523087
[TBL] [Abstract][Full Text] [Related]
4. Modulation of irinotecan metabolism by ketoconazole.
Kehrer DF; Mathijssen RH; Verweij J; de Bruijn P; Sparreboom A
J Clin Oncol; 2002 Jul; 20(14):3122-9. PubMed ID: 12118026
[TBL] [Abstract][Full Text] [Related]
5. A mechanistic study on altered pharmacokinetics of irinotecan by St. John's wort.
Hu ZP; Yang XX; Chen X; Cao J; Chan E; Duan W; Huang M; Yu XQ; Wen JY; Zhou SF
Curr Drug Metab; 2007 Feb; 8(2):157-71. PubMed ID: 17305494
[TBL] [Abstract][Full Text] [Related]
6. St. John's Wort modulates the toxicities and pharmacokinetics of CPT-11 (irinotecan) in rats.
Hu Z; Yang X; Ho PC; Chan E; Chan SY; Xu C; Li X; Zhu YZ; Duan W; Chen X; Huang M; Yang H; Zhou S
Pharm Res; 2005 Jun; 22(6):902-14. PubMed ID: 15948034
[TBL] [Abstract][Full Text] [Related]
7. St John's wort induces both cytochrome P450 3A4-catalyzed sulfoxidation and 2C19-dependent hydroxylation of omeprazole.
Wang LS; Zhou G; Zhu B; Wu J; Wang JG; Abd El-Aty AM; Li T; Liu J; Yang TL; Wang D; Zhong XY; Zhou HH
Clin Pharmacol Ther; 2004 Mar; 75(3):191-7. PubMed ID: 15001970
[TBL] [Abstract][Full Text] [Related]
8. St John's Wort: effect on CYP3A4 activity.
Roby CA; Anderson GD; Kantor E; Dryer DA; Burstein AH
Clin Pharmacol Ther; 2000 May; 67(5):451-7. PubMed ID: 10824623
[TBL] [Abstract][Full Text] [Related]
9. St. John's wort attenuates irinotecan-induced diarrhea via down-regulation of intestinal pro-inflammatory cytokines and inhibition of intestinal epithelial apoptosis.
Hu ZP; Yang XX; Chan SY; Xu AL; Duan W; Zhu YZ; Sheu FS; Boelsterli UA; Chan E; Zhang Q; Wang JC; Ee PL; Koh HL; Huang M; Zhou SF
Toxicol Appl Pharmacol; 2006 Oct; 216(2):225-37. PubMed ID: 17015070
[TBL] [Abstract][Full Text] [Related]
10. Effect of St John's wort on drug metabolism by induction of cytochrome P450 3A4 enzyme.
Markowitz JS; Donovan JL; DeVane CL; Taylor RM; Ruan Y; Wang JS; Chavin KD
JAMA; 2003 Sep; 290(11):1500-4. PubMed ID: 13129991
[TBL] [Abstract][Full Text] [Related]
11. Influence of phenytoin on the disposition of irinotecan: a case report.
Murry DJ; Cherrick I; Salama V; Berg S; Bernstein M; Kuttesch N; Blaney SM
J Pediatr Hematol Oncol; 2002 Feb; 24(2):130-3. PubMed ID: 11990699
[TBL] [Abstract][Full Text] [Related]
12. St John's Wort induces intestinal P-glycoprotein/MDR1 and intestinal and hepatic CYP3A4.
Dürr D; Stieger B; Kullak-Ublick GA; Rentsch KM; Steinert HC; Meier PJ; Fattinger K
Clin Pharmacol Ther; 2000 Dec; 68(6):598-604. PubMed ID: 11180019
[TBL] [Abstract][Full Text] [Related]
13. Effect of milk thistle (Silybum marianum) on the pharmacokinetics of irinotecan.
van Erp NP; Baker SD; Zhao M; Rudek MA; Guchelaar HJ; Nortier JW; Sparreboom A; Gelderblom H
Clin Cancer Res; 2005 Nov; 11(21):7800-6. PubMed ID: 16278402
[TBL] [Abstract][Full Text] [Related]
14. The effect of St John's wort on the pharmacokinetics of docetaxel.
Goey AK; Meijerman I; Rosing H; Marchetti S; Mergui-Roelvink M; Keessen M; Burgers JA; Beijnen JH; Schellens JH
Clin Pharmacokinet; 2014 Jan; 53(1):103-10. PubMed ID: 24068654
[TBL] [Abstract][Full Text] [Related]
15. Induction and inhibition of cytochromes P450 by the St. John's wort constituent hyperforin in human hepatocyte cultures.
Komoroski BJ; Zhang S; Cai H; Hutzler JM; Frye R; Tracy TS; Strom SC; Lehmann T; Ang CY; Cui YY; Venkataramanan R
Drug Metab Dispos; 2004 May; 32(5):512-8. PubMed ID: 15100173
[TBL] [Abstract][Full Text] [Related]
16. Herb-drug interactions with St John's wort (Hypericum perforatum): an update on clinical observations.
Borrelli F; Izzo AA
AAPS J; 2009 Dec; 11(4):710-27. PubMed ID: 19859815
[TBL] [Abstract][Full Text] [Related]
17. The effects of St John's wort (Hypericum perforatum) on human cytochrome P450 activity.
Wang Z; Gorski JC; Hamman MA; Huang SM; Lesko LJ; Hall SD
Clin Pharmacol Ther; 2001 Oct; 70(4):317-26. PubMed ID: 11673747
[TBL] [Abstract][Full Text] [Related]
18. Different effects of St John's wort on the pharmacokinetics of simvastatin and pravastatin.
Sugimoto K; Ohmori M; Tsuruoka S; Nishiki K; Kawaguchi A; Harada K; Arakawa M; Sakamoto K; Masada M; Miyamori I; Fujimura A
Clin Pharmacol Ther; 2001 Dec; 70(6):518-24. PubMed ID: 11753267
[TBL] [Abstract][Full Text] [Related]
19. Drug interactions with St John's wort : mechanisms and clinical implications.
Mannel M
Drug Saf; 2004; 27(11):773-97. PubMed ID: 15350151
[TBL] [Abstract][Full Text] [Related]
20. An update on clinical drug interactions with the herbal antidepressant St. John's wort.
Zhou SF; Lai X
Curr Drug Metab; 2008 Jun; 9(5):394-409. PubMed ID: 18537576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
